Madhumathi Palaniappan's Profile
B.Pharm
Madhu, an alumni of Madras Medical College writes on drugs and handles the drug section on Medindia. Her long term dream and desire is to become an entrepreneur in the Pharma field.
Written / Edited / Medically Reviewed
FDA Approves Probuphine for Maintenance Treatment of Opioid Dependence
The United States Food and Drug Administration Agency has approved Probuphine, the first buprenorphine implant to treat opioid dependence for a period of six months
Essential Drugs Are Made Cheaper by 55% in India
The National Pharmaceutical Pricing Authority of India reduces the prices of various drugs used in the treatment of cancer, diabetes and other critical diseases.
Smart Drug ‘Synapsyl’ Fuels For a More Powerful Brain
Smart drug synapsyl is used as a cognitive enhancer by students, scientists and entrepreneurs for improving memory power and to elevate the energy levels.
Drug Overdose
Drug overdose involves the intake of drug in excessive quantity than the recommended dose. It is due to overuse of over-the-counter medications or illegal drugs.
'Miracle Drug' Bedaquiline on Trial for Multidrug Resistance Tuberculosis (MDR-TB)
Multidrug resistant tuberculosis occurs due to the bacterial resistance for the first line anti-TB drugs. Bedaquiline a miracle drug has the potential to save many lives and eradicate the infection.